The renal excretory function of rats was investigated under conditions of reduced extracellular fluid volume (ECV) obtained by peritoneal dialysis with isotonic glucose solution 10% of the body mass and using sodium-deficient diet (consisting of boiled rice) with intact renin-angiotensin system (RAS) and after angiotensin converting enzyme blockade by Captopril. The experiments were made on male Wistar rats placed in metabolic cages. The diuresis, the excretion of sodium, potassium, chlorine and osmotically active substances in spontaneously released urine were tested over a period of 6 hours. Captopril was administered with Alzet osmotic minipumps at 80 micrograms/h rate of infusion (in the experimental animals with peritoneal dialysis) and intraperitoneally 1 mg/kg (in the animals subjected to sodium-deficient diet). Blocking of the converting enzyme with Captopril was found to increase the diuresis, as well as the sodium and total osmotic excretion after peritoneal dialysis and under sodium-deficient regime. Blocking of RAS with Captopril reduced the adaptive possibilities of the organism in the cases of reduced ECV and sodium-deficient diet.
Download full-text PDF |
Source |
---|
Cureus
December 2024
Nephrology, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, PRT.
Exit-site infections (ESIs) of peritoneal dialysis catheters can cause serious complications if not promptly treated. Uncommon pathogens like are infrequently associated with these infections. We report a 26-year-old woman with end-stage renal disease due to Alport syndrome, presenting with recurrent purulent discharge and erythema at the Tenckhoff catheter exit site.
View Article and Find Full Text PDFAdv Nutr
January 2025
Department of Nephrology, The Scarborough Health Network, Toronto, Ontario, Canada; Kidney Life Sciences Institute, Toronto, Ontario, Canada.
Managing diabetes in patients on peritoneal dialysis (PD) is challenging due to the combined effects of dietary glucose, glucose from dialysate, and other medical complications. Advances in technology that enable continuous biological data collection are transforming traditional management approaches. This review explores how multi-omics technologies and artificial intelligence (AI) are enhancing glucose management in this patient population.
View Article and Find Full Text PDFBackground Dry weight management in dialysis patients is crucial but often subjective, primarily based on symptoms. Due to continuous fluid removal in peritoneal dialysis (PD) and intermittent ultrafiltration in hemodialysis (HD), symptom-based assessments may be biased, leading to varying results. Surprisingly, no direct comparison of dry weight changes between PD and HD has been conducted.
View Article and Find Full Text PDFPediatr Int
January 2025
Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.
Perit Dial Int
January 2025
Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
There is growing emphasis on increasing utilization of peritoneal dialysis (PD) in patients with end stage kidney disease (ESKD); however, use in patients with severe obesity has still been fraught for various reasons. We aim to assess the viability of PD in patients with severe obesity (BMI > 40 Kg/m). We conducted a retrospective chart review of patients admitted at the home dialysis center of an academic center between 2014 and 2020 (n = 99).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!